Logo image of DOW

DOW INC (DOW) Stock Fundamental Analysis

NYSE:DOW - New York Stock Exchange, Inc. - US2605571031 - Common Stock - Currency: USD

20.87  -0.35 (-1.65%)

After market: 20.8999 +0.03 (+0.14%)

Fundamental Rating

3

Taking everything into account, DOW scores 3 out of 10 in our fundamental rating. DOW was compared to 85 industry peers in the Chemicals industry. DOW has a bad profitability rating. Also its financial health evaluation is rather negative. DOW is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year DOW was profitable.
DOW had a positive operating cash flow in the past year.
In the past 5 years DOW has always been profitable.
Each year in the past 5 years DOW had a positive operating cash flow.
DOW Yearly Net Income VS EBIT VS OCF VS FCFDOW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B

1.2 Ratios

Looking at the Return On Assets, with a value of -1.69%, DOW is doing worse than 63.53% of the companies in the same industry.
DOW's Return On Equity of -5.77% is on the low side compared to the rest of the industry. DOW is outperformed by 63.53% of its industry peers.
DOW has a worse Return On Invested Capital (1.24%) than 70.59% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DOW is in line with the industry average of 6.57%.
Industry RankSector Rank
ROA -1.69%
ROE -5.77%
ROIC 1.24%
ROA(3y)3.48%
ROA(5y)4.48%
ROE(3y)10.49%
ROE(5y)15.16%
ROIC(3y)4.98%
ROIC(5y)6.12%
DOW Yearly ROA, ROE, ROICDOW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

DOW's Profit Margin has declined in the last couple of years.
DOW has a Operating Margin of 1.93%. This is in the lower half of the industry: DOW underperforms 69.41% of its industry peers.
DOW's Operating Margin has declined in the last couple of years.
DOW has a worse Gross Margin (8.03%) than 83.53% of its industry peers.
In the last couple of years the Gross Margin of DOW has declined.
Industry RankSector Rank
OM 1.93%
PM (TTM) N/A
GM 8.03%
OM growth 3Y-32.39%
OM growth 5Y-11.56%
PM growth 3Y-39.18%
PM growth 5YN/A
GM growth 3Y-18.23%
GM growth 5Y-6.06%
DOW Yearly Profit, Operating, Gross MarginsDOW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

2

2. Health

2.1 Basic Checks

DOW has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
DOW has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, DOW has less shares outstanding
DOW has a worse debt/assets ratio than last year.
DOW Yearly Shares OutstandingDOW Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
DOW Yearly Total Debt VS Total AssetsDOW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

Based on the Altman-Z score of 1.56, we must say that DOW is in the distress zone and has some risk of bankruptcy.
DOW has a Altman-Z score of 1.56. This is in the lower half of the industry: DOW underperforms 65.88% of its industry peers.
DOW has a Debt/Equity ratio of 0.95. This is a neutral value indicating DOW is somewhat dependend on debt financing.
DOW has a worse Debt to Equity ratio (0.95) than 67.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Altman-Z 1.56
ROIC/WACC0.15
WACC8.44%
DOW Yearly LT Debt VS Equity VS FCFDOW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

DOW has a Current Ratio of 1.69. This is a normal value and indicates that DOW is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.69, DOW is doing worse than 61.18% of the companies in the same industry.
DOW has a Quick Ratio of 1.05. This is a normal value and indicates that DOW is financially healthy and should not expect problems in meeting its short term obligations.
DOW has a worse Quick ratio (1.05) than 61.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.05
DOW Yearly Current Assets VS Current LiabilitesDOW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

The earnings per share for DOW have decreased strongly by -96.74% in the last year.
Measured over the past years, DOW shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.16% on average per year.
The Revenue has decreased by -2.82% in the past year.
Measured over the past years, DOW shows a small growth in Revenue. The Revenue has been growing by 0.01% on average per year.
EPS 1Y (TTM)-96.74%
EPS 3Y-42.47%
EPS 5Y-12.16%
EPS Q2Q%-161.76%
Revenue 1Y (TTM)-2.82%
Revenue growth 3Y-7.88%
Revenue growth 5Y0.01%
Sales Q2Q%-7.43%

3.2 Future

Based on estimates for the next years, DOW will show a very strong growth in Earnings Per Share. The EPS will grow by 22.45% on average per year.
DOW is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.26% yearly.
EPS Next Y-96.33%
EPS Next 2Y-24.66%
EPS Next 3Y-0.67%
EPS Next 5Y22.45%
Revenue Next Year-4.79%
Revenue Next 2Y-0.99%
Revenue Next 3Y0.52%
Revenue Next 5Y1.26%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DOW Yearly Revenue VS EstimatesDOW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
DOW Yearly EPS VS EstimatesDOW Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 298.14 indicates a quite expensive valuation of DOW.
Based on the Price/Earnings ratio, DOW is valued a bit more expensive than the industry average as 68.24% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 26.41, DOW is valued quite expensively.
The Price/Forward Earnings ratio is 21.50, which indicates a rather expensive current valuation of DOW.
The rest of the industry has a similar Price/Forward Earnings ratio as DOW.
When comparing the Price/Forward Earnings ratio of DOW to the average of the S&P500 Index (33.87), we can say DOW is valued slightly cheaper.
Industry RankSector Rank
PE 298.14
Fwd PE 21.5
DOW Price Earnings VS Forward Price EarningsDOW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DOW is valued a bit cheaper than the industry average as 72.94% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.84
DOW Per share dataDOW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.66%
EPS Next 3Y-0.67%

6

5. Dividend

5.1 Amount

DOW has a Yearly Dividend Yield of 6.48%, which is a nice return.
In the last 3 months the price of DOW has falen by -30.87%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 3.76, DOW pays a better dividend. On top of this DOW pays more dividend than 89.41% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, DOW pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.48%

5.2 History

DOW has paid a dividend for at least 10 years, which is a reliable track record.
As DOW did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years5
DOW Yearly Dividends per shareDOW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

DOW has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-198.39%
EPS Next 2Y-24.66%
EPS Next 3Y-0.67%
DOW Yearly Income VS Free CF VS DividendDOW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B

DOW INC

NYSE:DOW (8/11/2025, 7:14:57 PM)

After market: 20.8999 +0.03 (+0.14%)

20.87

-0.35 (-1.65%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-23 2025-10-23/amc
Inst Owners67.51%
Inst Owner Change-0.24%
Ins Owners0.14%
Ins Owner Change14.28%
Market Cap14.79B
Analysts55.86
Price Target31.87 (52.71%)
Short Float %4.48%
Short Ratio2.43
Dividend
Industry RankSector Rank
Dividend Yield 6.48%
Yearly Dividend2.8
Dividend Growth(5Y)N/A
DP-198.39%
Div Incr Years0
Div Non Decr Years5
Ex-Date08-29 2025-08-29 (0.35)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)81.78%
Min EPS beat(2)-138.3%
Max EPS beat(2)301.86%
EPS beat(4)2
Avg EPS beat(4)16.36%
Min EPS beat(4)-138.3%
Max EPS beat(4)301.86%
EPS beat(8)5
Avg EPS beat(8)11.84%
EPS beat(12)8
Avg EPS beat(12)11.61%
EPS beat(16)12
Avg EPS beat(16)10.6%
Revenue beat(2)1
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-2.23%
Max Revenue beat(2)0.85%
Revenue beat(4)2
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-2.23%
Max Revenue beat(4)1.19%
Revenue beat(8)4
Avg Revenue beat(8)-0.1%
Revenue beat(12)7
Avg Revenue beat(12)0.61%
Revenue beat(16)9
Avg Revenue beat(16)0.83%
PT rev (1m)-16.77%
PT rev (3m)-16.58%
EPS NQ rev (1m)-525.3%
EPS NQ rev (3m)-140.35%
EPS NY rev (1m)0%
EPS NY rev (3m)-95.71%
Revenue NQ rev (1m)-3.42%
Revenue NQ rev (3m)-8.07%
Revenue NY rev (1m)-1.48%
Revenue NY rev (3m)-1.84%
Valuation
Industry RankSector Rank
PE 298.14
Fwd PE 21.5
P/S 0.35
P/FCF N/A
P/OCF 11.98
P/B 0.86
P/tB 2.14
EV/EBITDA 7.84
EPS(TTM)0.07
EY0.34%
EPS(NY)0.97
Fwd EY4.65%
FCF(TTM)-2.28
FCFYN/A
OCF(TTM)1.74
OCFY8.35%
SpS59
BVpS24.31
TBVpS9.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.69%
ROE -5.77%
ROCE 1.66%
ROIC 1.24%
ROICexc 1.31%
ROICexgc 1.68%
OM 1.93%
PM (TTM) N/A
GM 8.03%
FCFM N/A
ROA(3y)3.48%
ROA(5y)4.48%
ROE(3y)10.49%
ROE(5y)15.16%
ROIC(3y)4.98%
ROIC(5y)6.12%
ROICexc(3y)5.34%
ROICexc(5y)6.58%
ROICexgc(3y)7.02%
ROICexgc(5y)8.73%
ROCE(3y)6.67%
ROCE(5y)8.19%
ROICexcg growth 3Y-37.36%
ROICexcg growth 5Y-11.15%
ROICexc growth 3Y-36.83%
ROICexc growth 5Y-10.38%
OM growth 3Y-32.39%
OM growth 5Y-11.56%
PM growth 3Y-39.18%
PM growth 5YN/A
GM growth 3Y-18.23%
GM growth 5Y-6.06%
F-Score2
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Debt/EBITDA 4.39
Cap/Depr 97.27%
Cap/Sales 6.82%
Interest Coverage 250
Cash Conversion 33.06%
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.05
Altman-Z 1.56
F-Score2
WACC8.44%
ROIC/WACC0.15
Cap/Depr(3y)86.15%
Cap/Depr(5y)75.88%
Cap/Sales(3y)5.12%
Cap/Sales(5y)4.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.74%
EPS 3Y-42.47%
EPS 5Y-12.16%
EPS Q2Q%-161.76%
EPS Next Y-96.33%
EPS Next 2Y-24.66%
EPS Next 3Y-0.67%
EPS Next 5Y22.45%
Revenue 1Y (TTM)-2.82%
Revenue growth 3Y-7.88%
Revenue growth 5Y0.01%
Sales Q2Q%-7.43%
Revenue Next Year-4.79%
Revenue Next 2Y-0.99%
Revenue Next 3Y0.52%
Revenue Next 5Y1.26%
EBIT growth 1Y-58.9%
EBIT growth 3Y-37.72%
EBIT growth 5Y-11.56%
EBIT Next Year26.11%
EBIT Next 3Y26.93%
EBIT Next 5Y24.7%
FCF growth 1Y-142.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.07%
OCF growth 3Y-25.36%
OCF growth 5Y-13.25%